The study was supported by KindredBio as part of the new animal drug approval application to FDA. Given that this was a clinical study conducted as part of the new animal drug approval process and enrolled client-owned horses, informed owner con- sent was obtained prior to enrollment for each horse.
Declaration of Ethics
The Authors have adhered to the Principles of the Veterinary Medical Ethics of the AVMA.
Conflict of Interest
The Authors are employees of KindredBio. Kin- dredBio is currently seeking FDA approval of Dipyrone.